Hold and Release Procedure for Incoming Shipments and Production Lots

Hold and Release Procedure for Incoming Shipments and Production Lots

A hold label is easy to print. The hard part is ensuring that nobody uses, ships, reworks, or quietly relabels the material before the right evidence and authority are in place.

A hold and release procedure is a status-control system that identifies and controls incoming shipments, in-process lots, or finished goods pending a defined evaluation and authorized disposition. It links physical or digital segregation, records, risk triage, inspection or testing, authority, and final status. It is not a label alone or a substitute for applicable product, contract, or regulatory requirements.

The system must control both the material and the decision. A hold and release procedure is only eficaz when those controls agree.

Table of contents

What is a hold and release procedure?

A hold and release procedure is a written workflow that assigns a unique identity and status to material, prevents unintended use, defines the required evaluation, and authorizes release, rejection, rework, return, or another controlled disposition.

Drug-manufacturing requirements are not a universal template, but 21 CFR Part 211 illustrates the control principle. It assigns drug calidad units approval or rejection authority and describes separate or defined control systems for withholding material pending evaluation, holding rejected material, quarantine before release, and storage after release.[^1]

For general manufacturing, the specific statuses and controls must be based on the product, risk, contract, system, and applicable rules.

Status Practical meaning Boundary
Hold Material requires a defined review before normal use or shipment Hold does not automatically mean rejected
Quarantine Controlled location or status preventing unintended use pending disposition A physical area alone is not enough without identity and records
Released Material has completed the defined checks and authorized decision Release does not erase traceability or future complaint responsibility
Rejected Material is not acceptable for intended use under the defined requirement Rejection needs controlled disposition to prevent unintended reuse
Rework or return pending Material may undergo a separately authorized path It must not re-enter normal stock without applicable evaluation
Conditional or partial release A defined, bounded scope is released under written conditions It must not bypass safety, regulatory, or contract requirements

A hold and release procedure should make the current status obvious to anyone who can move or use the material.

Which statuses should the procedure distinguish?

Status names can vary. A clear hold and release procedure defines their meaning before material reaches the warehouse or production line. What matters is that operators, warehouse staff, quality staff, and systems interpret them consistently and that the material cannot move from one status to another without an authorized record.

Required distinction Why it matters
Identity and quantity Connects the hold to the exact received or produced population
Reason for hold Tells reviewers whether the issue is documentation, damage, test result, proveedor deviation, or another condition
Scope Prevents one carton or sample from being confused with an entire lot
Physical and system location Stops material from appearing available in one place and held in another
Required evidence Defines the inspection, test, document review, or investigation route
Disposition authority States who can approve the next status under the controlled process
Final record Preserves what was decided, why, and under which conditions

FDA’s Q7A guidance for APIs says materials should not be released or used before satisfactory evaluation by the quality unit unless appropriate systems allow use, and that persons authorized to release should be specified.[^2] That is a helpful design principle for a hold and release procedure, not a universal authorization chart.

How should material be placed on hold?

A hold must be created quickly enough to prevent use, but accurately enough that the equipo can trace what is held and why. This is the first operational test of a hold and release procedure. The first record should be factual; root cause can come later.

Hold step Record or control
Trigger Receipt pending review, damaged shipment, nonconformance, missing document, test result, deviation, complaint, or other defined event
Identification PO, lot, batch, serial, order, SKU, quantity, source, and location as applicable
Status application Controlled label, container, location, inventory status, or system block appropriate to the operation
Scope decision What exact material is held and what related population is potentially affected
Reason and evidence Observable condition, reference requirement, photos, document gap, test data, and detection time
Access control Who may sample, move, test, inspect, or alter the held material
Review assignment Owner, required evidence, target review point, and release authority

A hold and release procedure should never rely only on a handwritten label where the inventory system shows the same material as free stock.

How should evaluation and release work?

The evaluation route should be proportional to the risk and the reason for hold. The hold and release procedure should state this route before an urgent shipment creates pressure. A missing document may need a different review than physical damage or a critical test failure.

Evaluation question Decision route
Is identity established? Confirm the material and record link before interpreting any test or document
Is the scope known? Define the specific population and related material requiring review
What requirement is at issue? Reference the applicable specification, contract, inspection plan, or controlled procedure
What evidence is needed? Define document review, inspection, test, supplier response, or investigation under the approved method
Does evidence apoyo normal release? Obtain authorized release only after the defined checks are complete
Is another disposition needed? Use controlled rework, return, rejection, destruction, conditional release, or escalation process
Is traceability updated? Reconcile location, status, quantity, records, and downstream handoff

A test result alone does not release material if the sample identity, lot scope, specification, deviation record, or authority remains unresolved. The hold and release procedure should require all relevant release checks, not a single convenient result.

When can a partial release be considered?

Partial release can reduce unnecessary delay only when the released scope is clear, the risk is understood, and the written conditions do not conflict with a contractual, safety, regulatory, or quality requirement. It should not become a routine workaround for incomplete evaluation.

Partial-release question Control to define
What is being released? Exact lot segment, quantity, serial range, location, or customer allocation
What evidence supports that boundary? Traceability, sampling or test linkage, inspection result, and documented scope rationale
What remains on hold? Status, location, quantity, reason, and required next evidence
Who may authorize it? Role defined in the applicable controlled procedure and contract
What conditions apply? Use restriction, shipment restriction, additional inspection, recall linkage, or expiry of the decision as applicable
How is downstream use controlled? Clear communication and system status that prevents scope creep

A hold and release procedure should treat partial release as a written exception path with a defined boundary, not as an informal promise that the rest of the lot will be fine.

How should aged holds be managed?

Material can become a bigger problem while it sits. Evidence is lost, packaging changes condition, stock records diverge, and an old hold can be mistaken for available inventory.

Aged-hold review item Objetivo
Current identity, quantity, and location Reconciles records with actual material
Reason and outstanding evidence Shows why the item remains held
Product and storage condition Identifies whether time, expiry, or damage changes the disposition question
Supplier and owner action Escalates an unresolved response or decision
Next decision date Prevents indefinite holds without review
Final route Release, return, rework, rejection, destruction, or other authorized disposition

Use meaningful internal measures, such as the count and age of held items, only after defining the scope, owner, and interpretation. An aged-hold metric should reveal unresolved risk, not pressure teams into weak releases.

What are the limits of a hold-and-release system?

A status-control system cannot repair a poor specification, validate a test method, establish product safety, or decide contractual liability. It also cannot stop unintended use if staff bypass the physical and digital controls.

Limit Practical response
Hold reason is unclear Preserve facts, identify the requirement, and assign qualified review before disposition
Traceability is incomplete State the uncertainty and use a risk-based containment scope
Test method is unsuitable Obtain qualified technical direction rather than treating a result as decisive
Inventory status conflicts with physical status Stop movements and reconcile before any release
Supplier document arrives late Confirm identity, scope, adequacy, and authority before removing hold
Product is regulated or safety-critical Follow applicable product, regulatory, and quality-system requirements with qualified personnel

The strongest hold and release procedure controls the handoffs between warehouse, quality, production, supplier, and customer records. That is where held material most often escapes.

Frequently asked questions

What is a hold and release procedure?

A hold and release procedure is a written system for controlling material pending evaluation and authorizing release, rejection, rework, return, or another documented disposition.

Is a hold the same as rejection?

No. A hold means evaluation is pending. Rejection is a final status when the material is not acceptable for its intended use.

What should a hold label include?

Use the organization’s controlled format to identify the material, status, reason, scope, date, record reference, and access or disposition restrictions as needed.

Can a test result release a shipment automatically?

Not necessarily. Confirm sample identity, population scope, applicable requirement, deviations, documentation, and authorized release before changing status.

When is partial release appropriate?

Only when the released scope is traceable, evidence supports the defined boundary, conditions are written, authority is clear, and no requirement prohibits it.

Who may release material?

The applicable procedure, contract, and product requirements should define the authorized role. Do not infer authority from job title alone.

How should held stock be kept separate?

Use suitable physical and digital controls so held material cannot be mistaken for available stock. The method depends on the operation and product risk.

What happens if a held lot is already partly used?

Trace the known use, define the uncertainty, contain the appropriate population, and follow the controlled investigation and disposition route.

How often should aged holds be reviewed?

Set a documented review cadence appropriate to product risk, shelf life, storage, business impact, and applicable requirements rather than using a universal interval.

Can a supplier remove a hold by sending a certificate?

A supplier document can be evidence, but the authorized organization still needs to verify its link, scope, adequacy, and effect on the held material.

What is the practical rule?

Do not release material because it is inconvenient to hold. Release only when identity, scope, evidence, status, and authority are connected in the record. That is the practical rule for a hold and release procedure.

Referencias

[^1]: eCFR, “21 CFR Part 211, Current Good Manufacturing Practice for Finished Pharmaceuticals”

[^2]: FDA, “Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients”

Scroll al inicio